Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-24-046080
Filing Date
2024-11-14
Accepted
2024-11-14 17:24:51
Documents
76
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm   iXBRL 10-Q/A 1276412
2 ex31-1.htm EX-31.1 18521
3 ex31-2.htm EX-31.2 18214
4 ex32-1.htm EX-32.1 8450
5 ex32-2.htm EX-32.2 8941
  Complete submission text file 0001493152-24-046080.txt   7577048

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cdt-20240630.xsd EX-101.SCH 49681
7 XBRL CALCULATION FILE cdt-20240630_cal.xml EX-101.CAL 64250
8 XBRL DEFINITION FILE cdt-20240630_def.xml EX-101.DEF 270304
9 XBRL LABEL FILE cdt-20240630_lab.xml EX-101.LAB 450628
10 XBRL PRESENTATION FILE cdt-20240630_pre.xml EX-101.PRE 387460
78 EXTRACTED XBRL INSTANCE DOCUMENT form10-qa_htm.xml XML 1306481
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-41245 | Film No.: 241464468
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)